Abstract
Introduction
Individuals' burden of insulin resistance and metabolic syndrome, such as type 2 diabetes mellitus, is increasing. This indicates to intrigue into various facets of prevention, early screening, prognostication and feasible treatment alternatives in this arena.
Aim
This study targets to evaluate iron profile status among people diagnosed with type 2 diabetes mellitus and normoglycemic in order to deduce association between iron parameters and insulin resistance, if any exist.
Methodology
A case-control study of total 123 subjects, comprising males and females in the age group of 30 - 70 years were recruited for the study. Case group constituted 81 participants who were diagnosed with type 2 diabetes mellitus and control group constituted 42 healthy individuals who attended routine health check-ups in the hospital. Iron profile parameters including Serum Iron, Serum Ferritin, Total Iron binding Capacity and Glycemic profile parameter like fasting blood glucose, serum insulin were estimated. Transferrin saturation and HOMA-IR were calculated.
Result
Ferritin and Transferrin saturation was found to be higher in cases than in controls with significance of p = 0.003 and p = 0.021 respectively and TIBC (total iron-binding capacity) was lesser in cases with p = 0.031. Comparison of Serum Iron values did not yield a significant result. Correlation study between ferritin and insulin resistance parameters yielded a satisfactory result in the cases (p<0.05) and controls (p<0.01) separately.
Conclusion
This study implies that there is a clear link between iron profile status, notably ferritin, and the emergence of insulin resistance, and hence insulin production. This study supports the function of the micronutrient iron in the etiology of type 2 diabetes and its consequences.
Similar content being viewed by others
References
Roglic G, World Health Organization, editors. Global report on diabetes. Geneva, Switzerland: World Health Organization; 2016. 86 p.
Jayawardena R, Ranasinghe P, Byrne NM, Soares MJ, Katulanda P, Hills AP. Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysis. BMC Public Health. 2012;12:380.
Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.
Forouhi NG, Misra A, Mohan V, Taylor R, Yancy W. Dietary and nutritional approaches for prevention and management of type 2 diabetes. BMJ. 2018;361:k2234.
Manikandan A, Ganesh M, Silambanan S. Study of iron status in type 2 diabetes mellitus. Int J Clin Biochem Res. 2015;2(2):77–82.
Swaminathan S, Fonseca VA, Alam MG, Shah SV. The Role of Iron in Diabetes and Its Complications. Diabetes Care. 2007;30(7):1926–33.
Yaribeygi H, Sathyapalan T, Atkin SL, Sahebkar A. Molecular mechanisms linking oxidative stress and diabetes mellitus. Oxid Med Cell Longev. 2020;2020:8609213.
Fernández-Real JM, Peñarroja G, Castro A, García-Bragado F, Hernández-Aguado I, Ricart W. Blood Letting in High-Ferritin Type 2 Diabetes: Effects on Insulin Sensitivity and β-Cell Function. Diabetes. 2002;51(4):1000–4.
Fernández-Real JM, López-Bermejo A, Ricart W. Cross-Talk Between Iron Metabolism and Diabetes. Diabetes. 2002;51(8):2348–54.
Raj S, Rajan GV. Correlation between elevated serum ferritin and HbA1c in type 2 diabetes mellitus. Int J Res Med Sci. 2017;1:12–5.
Kumar Sharma A, Singh Dhakad G, Kanwar G, Kumar Singh A, Sharma S. Evaluation of iron profile in type 2 diabetes mellitus patients of tertiary care center of central India. Int J ClinBiochem Res. 2019;6:15–9.
Borah M, Goswami RK. Evaluation of serum ferritin in type II diabetes mellitus: a hospital-based observational study from Dibrugarh, Assam, India. Int J Res Med Sci. 2016;4(11):4916–21.
Misra G, Bhatter S, Kumar A, Gupta V, Khan M. Iron profile and glycaemic control in patients with type 2 diabetes mellitus. Med Sci (Basel). 2016;4:22.
Zheng X, Jiang T, Wu H, Zhu D, Wang L, Qi R, et al. Hepatic iron stores are increased as assessed by magnetic resonance imaging in a Chinese population with altered glucose homeostasis. Am J ClinNutr. 2011;94:1012–9.
Elsayed ME, Sharif MU, Stack AG. Transferrin Saturation: A Body Iron Biomarker. AdvClin Chem. 2016;75:71–97. https://doi.org/10.1016/bs.acc.2016.03.002.
Ponsuganthi K, Ramya S. Association of serum iron and magnesium levels with lipid profile in type 2 diabetic patients. MedPulse I J Biochem. 2020;15:08–12.
Achuthan A, Mageswari U. Correlation between serum free iron, glycated hemoglobin and insulin resistance in uncontrolled type-2 diabetic patients. Natl J Physiol Pharm Pharmacol. 2017;7(6):642.
Wiltink WF, Kruithof J, Mol C, GréBos M, Van Eijk HG. Diurnal and nocturnal variations of the serum iron in normal subjects. ClinChimActa. 1973;49:99–104.
Vaquero MP, Martínez-Maqueda D, Gallego-Narbón A, Zapatera B, Pérez-Jiménez J. Relationship between iron status markers and insulin resistance: an exploratory study in subjects with excess body weight. PeerJ. 2020;8:e9528.
Chandrika N, Usha SMR. Analysis of serum ferritin levels in non-diabetic, prediabetic and diabetic individuals. Int J ClinBiochem Res. 2020;5:1–4.
Tuomainen TP, Nyyssönen K, Salonen R, Tervahauta A, Korpela H, Lakka T, Kaplan GA, Salonen JT. Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men. Diabetes Care. 1997;21(3):426–8.
Fernández-Real JM, López-Bermejo A, Ricart W. Iron stores, blood donation, and insulin sensitivity and secretion. Clin Chem. 2005;51(7):1201–5. https://doi.org/10.1373/clinchem.2004.046847.
Liu J, Li Q, Yang Y, Ma L. Iron metabolism and type 2 diabetes mellitus: A meta-analysis and systematic review. J Diabetes Investig. 2020;11:946–55.
Nasr M, Shaaban M, Dawod AE. Role of iron in diabetes mellitus and its complications. Menoufia Med J. 2016;29:11.
Wu W, Yuan J, Shen Y, Yu Y, Chen X, Zhang L, et al. Iron overload is related to elevated blood glucose levels in obese children and aggravates high glucose-induced endothelial cell dysfunction in vitro. BMJ Open Diabetes Res Care. 2020;8:e001426.
Thomas MC, MacIsaac RJ, Tsalamandris C, Jerums G. Elevated iron indices in patients with diabetes. Diabet Med. 2004;21(7):798–802. https://doi.org/10.1111/j.1464-5491.2004.01196.x.
Acknowledgement
The authors wish to express their heartfelt gratitude to the Indian Council of Medical Research for funding the project (ICMR STS 2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declared that they have no conflict of interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sam, R.M., Shetty, S.S., Kumari N, S. et al. Association between iron profile status and insulin resistance in patients with type 2 diabetes mellitus. J Diabetes Metab Disord 22, 1453–1458 (2023). https://doi.org/10.1007/s40200-023-01268-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40200-023-01268-4